The role of novel immunotherapies in non-Hodgkin lymphoma.
Sign Up to like & getrecommendations! Published in 2017 at "Translational cancer research"
DOI: 10.21037/tcr.2017.01.08
Abstract: Immunotherapy is an evolving modality in the treatment of non-Hodgkin lymphoma. Vaccinations with patient-specific tumor-derived antigens have been developed to strengthen immune response to tumor. The success of rituximab, a monoclonal antibody for CD20 on… read more here.
Keywords: lymphoma; immunotherapies non; hodgkin lymphoma; novel immunotherapies ... See more keywords